Fuss und Sprunggelenk最新文献_第2页

Einladung zur Mitgliederversammlung der Deutschen Assoziation für Fuß und Sprunggelenk e.V. 邀请参加德国足部和踝关节协会会员大会。

Fuss und Sprunggelenk Pub Date : 2025-03-01 DOI: 10.1016/j.fuspru.2025.02.001

引用次数: 0

Kongresskalender Kongresskalender

Fuss und Sprunggelenk Pub Date : 2025-03-01 DOI: 10.1016/S1619-9987(25)00020-0

引用次数: 0

Knochenmarködem – Ätiologie und Behandlung 骨质疏松症：病因与治疗

Fuss und Sprunggelenk Pub Date : 2025-03-01 DOI: 10.1016/j.fuspru.2025.01.004

F.P. Gaube , C. Behzadi , W. Böcker , H. Polzer , S.F. Baumbach

{"title":"Knochenmarködem – Ätiologie und Behandlung","authors":"F.P. Gaube , C. Behzadi , W. Böcker , H. Polzer , S.F. Baumbach","doi":"10.1016/j.fuspru.2025.01.004","DOIUrl":"10.1016/j.fuspru.2025.01.004","url":null,"abstract":"<div><div>Over the last decades, there has been a significant increase in the diagnosis of „bone marrow edema“ (BME). BME is primarily a radiological-descriptive term. It can be caused by a variety of physiological and pathophysiological processes. This narrative review aims to present a standardized diagnostic algorithm and summarize the existing evidence on adjunctive therapies.</div><div>The diagnostic algorithm is based on a sequential diagnostic approach, which includes MRI, X-ray/CT, basic laboratory tests, a detailed endocrinological laboratory workup, and DXA. This sequential process addresses traumatic, inflammatory, septic, mechanical/degenerative, ischemic/neurogenic, neoplastic, and metabolic causes of BME. Only when no specific cause has been identified, the BME should be classified as a bone marrow edema syndrome (BMES).</div><div>The cornerstone of BME therapy is identifying and treating the underlying pathology. Only by addressing the cause long-term recovery can be achieved. In addition to treating the primary disease—or in cases of isolated BMES—adjunctive conservative therapies (e.g., NSAIDs ± immobilization ± partial weight-bearing, shockwave therapy, pulsed electromagnetic fields) or pharmacological treatments (e.g., bisphosphonates or iloprost) may be considered. All pharmacological treatments are off-label and therefore require an informed consent. According to the authors, surgical treatment is not part of BME Management.</div></div>","PeriodicalId":39776,"journal":{"name":"Fuss und Sprunggelenk","volume":"23 1","pages":"Pages 2-14"},"PeriodicalIF":0.0,"publicationDate":"2025-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143679873","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Subchondral bone degeneration and pathology 3-15 years following ankle sprain injury in adolescent sport 青少年运动踝关节扭伤后3-15年的软骨下骨变性和病理

Fuss und Sprunggelenk Pub Date : 2025-03-01 DOI: 10.1016/j.fuspru.2025.01.001

M. Jordan

引用次数: 0

Nicht-invasive Kompartmendruckmessung von Patient:innnen mit dem Risiko eines akuten Kompartmentsyndroms nach Extremitätenverletzung mit dem CPMX1 非侵入性室间隔压力测量：在使用CPMX1治疗肢体损伤后有急性室间隔综合征风险的患者内部

Fuss und Sprunggelenk Pub Date : 2024-12-01 DOI: 10.1016/j.fuspru.2024.07.057

T. Gehlen, J.W. Kim, C. Eder, J. Löchel, U. Stöckle

引用次数: 0

Post Market Clinical Follow-Up Studie zur Erfassung der Qualität und Leistungsfähigkeit einer neuen Generation von Magnesiumschrauben in der Fuß- und Sprunggelenkchirurgie 新一代镁螺钉在足部和踝关节手术中的质量和性能的上市后临床随访研究

Fuss und Sprunggelenk Pub Date : 2024-12-01 DOI: 10.1016/j.fuspru.2024.07.063

T. Gehlen, H. Fischer, F. Graef, A. Alimrani, U. Stöckle, S. Tsitsilonis